The adoption of artificial intelligence in clinical practice has prompted a surge in randomized controlled trials, highlighting a balance of enthusiasm and prudence.
Aravax announces the appointment of Alex Williams as Chief Business Officer.
7th of May, 2025
Learn more8th of May, 2025
Learn more14th of May, 2025
Learn more15th of May, 2025
Learn moreThis website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings